Bristol-Myers Sqibb (BMY)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 33.09
   
  • Change Today:
    $0.10
  • 52 Week High: $35.29
  • 52 Week Low: $26.38
  • Currency: US Dollars
  • Shares Issued: 1,689.08m
  • Volume: 5,297,571
  • Market Cap: $55,892m
  • RiskGrade: 66
  • Beta: 0.53

BMY Overview

Bristol-Myers Squibb is a global producer and distributor of pharmaceuticals and other healthcare-related products. The merger of Bristol-Myers with Squibb in 1989 created what was then the world’s second-largest pharmaceutical enterprise. The company’s key business areas cover pharmaceuticals, infant formulas and nutritional products, ostomy & advanced wound care, cardiovascular imaging and over-the-counter products.

1 Day Chart (25-05-2012)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.0%
Div Cover 1.6
Op Mrgn 34.2%
ROCE 55.2%
Latest F'cast
P/E 15.2
PEG 0.7
Pr/Revenue 2.6
Pr/Book 3.5
Latest F'cast
Revenue 9.0%
PBT 15.0%
EPS 21.1%
DPS 3.1%

BMY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 18,193.00 3,186.00 110.00¢ 24.1 0.7 +36% 115.00¢ 4.3%
31-Dec-08 17,715.00 4,776.00 136.00¢ 17.1 0.7 +24% 124.00¢ 5.3%
31-Dec-09 18,808.00 5,602.00 163.00¢ 15.5 0.8 +20% 125.00¢ 5.0%
31-Dec-10 19,484.00 6,071.00 180.00¢ 14.7 1.5 +10% 129.00¢ 4.9%
31-Dec-11 21,244.00 6,981.00 218.00¢ 16.2 0.8 +21% 133.00¢ 3.8%

BMY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 17,925.54 5,236.21 195.36¢ 16.9 n/a -10% 135.90¢ 4.2%
31-Dec-13 16,791.41 4,472.44 192.02¢ 17.2 n/a -2% 137.72¢ 4.2%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

BMY ShareCast News

US close: Energy sapping day for US stocks 28-Mar-2012 ShareCast
Amylin rejects offer from Bristol-Myers 28-Mar-2012 ShareCast
US close: Stocks creep higher; Alcoa delivers mi... 09-Jan-2012 ShareCast

BMY Top Newspaper Links

Bristol-Myers, partner AstraZeneca get EU approv... 06-Oct-2009 Chicago Tribune
AstraZeneca's heart attack drug offers £5.5bn bo... 31-Aug-2009 Sunday Telegraph
Astra Zeneca gets US approval for diabetes drug ... 02-Aug-2009 Sunday Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

BMY Market Data

Currency US Dollars
Share Price $ 33.09
Change Today $ 0.10
% Change 0.30 %
52 Week High $35.29
52 Week Low $26.38
Volume 5,297,571
Shares Issued 1,689.08m
Market Cap $55,892m
Beta 0.53
RiskGrade 66

What The Brokers Say

Strong Buy 9
Buy 2
Neutral 10
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:15 269,066 @ $33.09
16:15 4,900 @ $33.09
16:15 4,000 @ $33.10
16:14 400 @ $33.10
16:14 200 @ $33.10

Top of Page